A Sheffield-based aquaculture biotechnology company says it has been through a “transformational” year after selling one of its key divisions for £260m in an effort to simplify its business model.

Global clinical trials market will reach $79,977.1 million by 2031, growing by 7.0% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel ...